Sentences with phrase «professor of oncology»

«Canine lymphoma is one of the most common types of cancer in dogs,» says Dr. Steven Suter, assistant professor of oncology.

Director of National Veterinary Laboratory Inc. and adjunct professor of oncology at University of Pennsylvania School of Veterinary Medicine

Withrow and MacEwen's Small Animal Clinical Oncology — Stephen J. Withrow, DVM, DACVIM (Oncology), Director, Animal Cancer Center Stuart Chair In Oncology, University Distinguished Professor, Colorado State University Fort Collins, Colorado; Research, School of Veterinary Medicine University of Wisconsin - Madison Madison, Wisconsin David M. Vail, DVM, DACVIM (Oncology), Professor of Oncology, Director of Clinical Research School of Veterinary Medicine University of Wisconsin - Madison, Madison Wisconsin

«Comparative Epigenomics: The Essential Exploration of the Canine Lymphoma Epigenome», presented by Dr. Angela McCleary - Wheeler, DVM, PhD, Assistant Professor of Oncology, Department of Clinical Sciences, Cornell College of Veterinary Medicine.

According to Margaret McEntee, DVM, a professor of oncology at Cornell University's College of Veterinary Medicine, approximately 85 percent of feline mammary cancers are lethally malignant adenocarcinomas.

Perlman Professor of Oncology / Comparative Medicine University of Minnesota College of Veterinary Medicine and Masonic Cancer Center

Karen Leshkivich, DVM Encyclopedia of Canine Veterinary Medical Information — Dr. Michael Richards, DVM Commonly Treated Malignancies of the Dog — Michael D. Lucroy, DVM, MS, DACVIM (Oncology); Associate Professor of Oncology; Kerr Foundation Chair for Biomedical Laser and Biophotonics Research, Department of Veterinary Clinical Sciences; College of Veterinary Medicine; Oklahoma State University

Withrow and MacEwen's Small Animal Clinical Oncology — Stephen J. Withrow, DVM, DACVIM (Oncology), Director, Animal Cancer Center Stuart Chair In Oncology, University Distinguished Professor, Colorado State University Fort Collins, Colorado; Research, School of Veterinary Medicine University of Wisconsin - Madison Madison, Wisconsin David M. Vail, DVM, DACVIM (Oncology), Professor of Oncology, Director of Clinical

Perlman Professor of Oncology / Comparative Medicine College of Veterinary Medicine and Masonic Cancer Center University of Minnesota

In July of 2007, Jaime joined the College of Veterinary Medicine, School of Medicine, and Masonic Cancer Center at the University of Minnesota, where he continues his research program as Alvin and June Perlman Endowed Professor of Oncology and Comparative Medicine and Director of the Animal Cancer Care and Research Program.

But some years ago, Karin Sorenmo, a professor of oncology at the University of Pennsylvania School of Veterinary Medicine, realized that homeless shelter dogs could contribute in important ways to the understanding of breast cancer.

In this December 17, 2012 photo provided by Colorado State University, Dr. Rodney L. Page, Professor of Oncology and Director of the CSU Flint Animal Cancer Center, sits on a sofa with a golden retriever, Winston, in the lobby of the James L. Voss Veterinary Teaching Hospital at Colorado State University, in Fort Collins, Colo..

Dr. Henry served as a faculty member at the Washington State University College of Veterinary Medicine for four years and joined the faculty of the University of Missouri in 1997 as an assistant professor of oncology, becoming the first American College of Veterinary Internal Medicine board - certified oncologist at MU.

From 2001 - 2010 he was an Assistant Professor of Oncology at Cornell, where his research efforts were focused on clinical and translational projects involving cancer control and pharmacological validation of new agents.

Dr. Heather Wilson - Robles is currently an associate professor of oncology and the Palmer Chair in Comparative Oncology at Texas A&M University (TAMU).

Withrow and MacEwen's Small Animal Clinical Oncology - Stephen J. Withrow, DVM, DACVIM (Oncology), Director, Animal Cancer Center Stuart Chair In Oncology, University Distinguished Professor, Colorado State University Fort Collins, Colorado; David M. Vail, DVM, DACVIM (Oncology), Professor of Oncology, Director of Clinical Research, School of Veterinary Medicine University of Wisconsin - Madison Madison, Wisconsin

«Some owners find it difficult to stop treatment,» says Karin Sorenmo, a professor of oncology at PennVet in Philadelphia, «but you can't think of it as giving up.

References Withrow and MacEwen's Small Animal Clinical Oncology - Stephen J. Withrow, DVM, DACVIM (Oncology), Director, Animal Cancer Center Stuart Chair In Oncology, University Distinguished Professor, Colorado State University Fort Collins, Colorado; David M. Vail, DVM, DACVIM (Oncology), Professor of Oncology, Director of Clinical Research, School of Veterinary Medicine University of Wisconsin - Madison Madison, Wisconsin

The faculty lead for the Comparative and Translational Oncology Signature program is Dr. Cheryl London, professor of oncology in the Departments of Veterinary Biosciences and Veterinary Clinical Sciences.

Dr. Modiano joined the College of Veterinary Mediine, School of Medicine, and masonic Cancer Center at the University of Minnesota in 2007, where he continues his research program as Alvin and June Perlman Endowed Professor of Oncology and Comparative medicine and Director of the Animal Cancer Care and Research Program.

Dr. Stephanie Schleis, an associate clinical professor of oncology, is Dr. Hagood's sponsor for his sabbatical, and said that having the veterinarians complete the program offers value to all participants.

He's an assistant professor of oncology at Roswell Park Comprehensive Cancer Center, in Buffalo, N.Y.

The new findings «just further substantiate what we know about this class of drugs,» says Charles Loprinzi, MD, a professor of oncology at the Mayo Clinic, in Rochester, Minn..

Fewer women are getting the disease The rate of new cases of ovarian cancer has declined by 1 % each year since 1992 (about 22,000 women will be diagnosed this year)-- possibly because so many women today are on the Pill, says Deborah Armstrong, MD, associate professor of oncology and OB - GYN at Johns Hopkins Kimmel Cancer Center in Baltimore.

«Much to our surprise, the trial showed that patients receiving standard therapy compared to those receiving cetuximab with standard therapy had no difference in outcomes,» said study author Dr. Steven Alberts, a professor of oncology at the Mayo Clinic College of Medicine in Rochester, Minn. «It also indicates that disease in earlier stages may be different than diseases in later stages.»

«This study suggests that smokers who completely switch to e-cigarettes and stop smoking tobacco cigarettes may significantly reduce their exposure to many cancer - causing chemicals,» said lead author Maciej Goniewicz, an assistant professor of oncology at Roswell Park Cancer Institute in Buffalo, N.Y.

Gal Shafirstein, DSc, Director of PDT Clinical Research, Professor of Oncology and member of the Cell Stress Biology Department at Roswell Park, points out that PDT treatment is intended to improve the cure rate for cancer.

The study's senior author is Fung - Lung Chung, professor of oncology.

Director, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Marion I. Knott Director and Professor of Oncology

The study suggests a research direction for examining the diet of pregnant women, says the study's senior author, Leena Hilakivi - Clarke, PhD, professor of oncology.

Vogelstein, a professor of oncology and pathology at Johns Hopkins University School of Medicine, was cited for his groundbreaking research in cancer genetics that has catalyzed new approaches to fighting the growth of malignant tumors.

One of the selected landmark studies presented a breakthrough in gene editing by Todd Waldman, MD, PhD, a professor of oncology at the Georgetown Lombardi Comprehensive Cancer Center and director of the Georgetown MD / PhD Program.

Dr. Matsuzaki joined the Roswell Park Comprehensive Cancer Center staff in April 2011 as Assistant Professor of Oncology and Director of the Immune Analysis Facility.

August 16, 2016 — It has been more than two decades since Todd Waldman, MD, PhD, a professor of oncology at the Georgetown Lombardi Comprehensive Cancer Center and director of the Georgetown MD / PhD Program, published a study that led in part to earning his own MD / PhD degree at the Johns Hopkins School of Medicine.

Results of the international trial, led by principal investigator Jeffrey S. Weber, MD, PhD, the Laura and Isaac Perlmutter Professor of Oncology, deputy director of Perlmutter Cancer Center, and co-leader of its Melanoma Research Program, were published in November 2017 in The New England Journal of Medicine.

«I am treating people today with pembrolizumab alone and seeing some impressive outcomes,» said Dr. Rosalyn Juergens, oncologist and site lead investigator at Hamilton Health Sciences» Juravinski Cancer Centre, and associate professor of oncology at McMaster University.

Dr. Schwaab is also a Professor of Oncology and Immunology, and joined the Institute's faculty in 2009.

«The mutational analysis of NOTCH clearly indicated the power of genetic changes determining the function of these genes,» said Kenneth W. Kinzler, professor of oncology and a molecular geneticist at Johns Hopkins, co-director of the Ludwig Center at Johns Hopkins, and an author of one of the Science papers.

Michelle Rudek, Pharm.D., Ph.D., is an associate professor of oncology at the Johns Hopkins University School of Medicine and director of the Analytical Pharmacology Core for the Johns Hopkins Kimmel Cancer Center.

Director, Thoracic Oncology Program Interim Director, Johns Hopkins Kimmel Cancer Center at Bayview Associate Professor of Oncology Sidney Kimmel Comprehensive Cancer Center Johns Hopkins School of Medicine Baltimore, MD

Dr. Wolff is an Associate Professor of Oncology and member of the Breast Cancer Research Program at The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.

«What we see is an association between shorter periods of progression - free survival and overall survival in patients whose blood has higher levels of hypermethylated DNA, and we can see this very early on, after just four weeks of treatment,» says Sara Sukumar, Ph.D., professor of oncology at the Johns Hopkins University School of Medicine and member of the Kimmel Cancer Center, who developed the test with Johns Hopkins scientist Mary Jo Fackler, Ph.D., and others.

Raymond Niaura, PhD, the study's leader and senior author, is an adjunct professor of oncology at Georgetown Lombardi, and associate director for science of the Schroeder Institute for Tobacco Research and Policy Studies in Washington.

«There's a great need in cancer patients to be able to quickly and easily assess if a particular treatment is working in order to switch to another if it's not, thus avoiding wasted time, potential side effects and cost,» says Kala Visvanathan, M.D., M.H.S., professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health, professor of oncology at the Johns Hopkins University School of Medicine and director of the Clinical Cancer Genetics Program at the Johns Hopkins Kimmel Cancer Center.

Todd Waldman is a Professor of Oncology at the Lombardi Comprehensive Cancer Center, Georgetown School of Medicine.

«It is difficult to dissuade children from smoking if one or both parents are heavily dependent on cigarettes,» says the study's lead investigator, Darren Mays, PhD, MPH, an assistant professor of oncology at Georgetown Lombardi.

Family history of breast cancer continues to significantly increase chances of developing invasive breast tumors in women ages 65 and older, according to research published by a team led by Dejana Braithwaite, PhD, associate professor of oncology at Georgetown University School of Medicine and a member of Georgetown Lombardi Comprehensive Cancer Center.

This study offers a greater understanding of the factors that influence that trajectory and can help inform clinicians on the next best therapy to administer at the time of relapse,» says Kevin Eng, PhD, lead author of the study and Assistant Professor of Oncology in the Department of Biostatistics and Bioinformatics at Roswell Park.

Michael Carducci, MD, AEGON Professor of Prostate Cancer Research and professor of oncology at Johns Hopkins Kimmel Cancer Center, who is also chair of the Prostate Cancer Subcommittee within the Genitourinary Oncology Committee of ECOG - ACRIN agrees.

«We urgently need markers to predict which therapies are going to be effective and which will not be effective in individual patients with advanced prostate cancer,» said lead study author Emmanuel Antonarakis, MD, an assistant professor of oncology and urology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, Md. «AR - V7 testing may be extremely valuable in guiding treatment decisions for men with hormone - resistant disease in the near future.»